Pharma
Top daily news that’s updated every 10 minutes. Click title to read on originating website
Providence, Luna Partner to Provide Patients At-Home Physical Therapy
Providence recently launched a program to expand its patients’ access to in-home physical therapy. The health system is...
Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps
Pear Therapeutics isn’t meeting the commercialization goals for its prescription digital therapeutics, so it’s now seeking...
What Keeps One Advocate up at Night About the No Surprises Act
Patricia Kelmar, healthcare campaigns director at the Public Interest Research Group, is an advocate for the No Surprises...
Why Point-of-Care Diagnostic Filtering, Interoperability Are Essential in the Age of TEFCA, QHINs
Without a new set of tools that clinicians can access at the point of care, the availability of information from QHINs will...
Preserve Access to Home Oxygen Therapy Post-Pandemic
CMS should honor its commitment to Medicare beneficiaries, especially those who began home respiratory therapy under the...
There Is ‘Skepticism and Support’ for National Provider Directory, CMS Official Says
CMS put out a request for information in October about a CMS-led national provider directory that would allow patients to...
Labcorp Shells Out $146M to Buy Enzo Biochem’s Clinical Lab Business
Enzo BioChem’s sale of its clinical lab business to Labcorp is the culmination of a monthslong strategic review. Meanwhile,...
Perspectum Completes $55M Series C to Improve Metabolic Disease Diagnosis
Perspectum — a company that makes medical imaging devices designed to improve the diagnosis of metabolic diseases and...
Pharmanovia signs licence deal for Aeterna Zentaris’ Ghryvelin
Pharmanovia and Aeterna Zentaris have entered an exclusive licensing agreement for the latter’s medicine Ghryvelin...
Tapping into digital therapeutics to improve neurological outcomes
As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly...
Risk sharing agreements soar as market access risk increases
Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex...
Great Ormond Street Hospital and Leucid Bio collaborate
GOSH will collaborate with Leucid at the Zayed Centre for Research into Rare Disease in Children
iOnctura reveals roginolisib research results
Therapy prevents tumour proliferation while breaking immune tolerance among cancer patients
LCRF, Daiichi Sankyo and AstraZeneca enter research collaboration
The Lung Cancer Research Foundation (LCRF) has announced a new research partnership with Daiichi Sankyo and AstraZeneca....
US FDA approves Novartis’ Tafinlar and Mekinist combination therapy
The US Food and Drug Administration (FDA) has granted approval for Novartis’ combination therapy, Tafinlar (dabrafenib) and...

hello@diviastrologist.com
phone
(255) 352-6258